What is EMBC's market cap?

$369.42M, based on the Nov 4 close of $6.52.

What is EMBC's P/E ratio?

4.2× trailing-twelve-month earnings of $87.50M.

Does Embecta pay a dividend?

Yes. The latest regular dividend was $0.01 per share (ex-date Aug 27), an annualised yield of 0.61%.

How much of EMBC is sold short?

5.9M shares, 10.5% of float, as of Oct 15, 2026.

What sector is EMBC in?

Healthcare, in the Surgical Instruments industry.

NASDAQ · EMBCHealthcareSurgical Instruments

Embecta Corp. Common Stock (EMBC)

$6.52+7.24%

Close Nov 4, 2026 · split-adjusted

Nov 4, 2026$6.62▼ 50.71% in range

Nov 3, 2025Low $2.90 · High $14.64Nov 4, 2026

What changed · written from our data

As of Nov 4, 2026

Embecta closed at $6.52 on Nov 4, up 7.24%, 55.5% below its 52-week closing high. Volume of 1.2M shares was 1.37× its 20-day average (above normal).

Split-adjusted performance: +9.6% over one month, +83.1% over six months, -51.4% over one year.

In the quarter ended Jun 30, 2026, revenue was $271.70M, down 8.1% from a year earlier, with a net margin of 7.8%.

Short interest was 5.9M shares at the Oct 15 settlement (10.5% of float, 6.2 days to cover).

Market cap$369.4M56.7M shares

Revenue · quarter$271.7M−8.1% YoY

Diluted EPS$0.36−53.8% YoY

P/E · TTM4.2×P/S 0.4×

Net margin7.8%Gross 56.4%

Dividend yield0.61%$0.01 last paid

52-week range2.90 – 14.64−55.5% from high

Volume1.2M1.37× 20-day avg

Volatility · 60d53.0%Annualised

Short % of float10.5%6.2 days to cover

Net cash-$1.27BCash $214.7M

Next earnings—Not scheduled

Split-adjusted performance

1W +0.9%1M +9.6%3M +86.3%6M +83.1%YTD −45.1%1Y −51.4%3Y −57.2%5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Surgical Instruments

Percentile among 110 companies (100 = best)

6-month momentum90

Revenue growth10

Net margin72

Value (low P/E)93

Size52

Industry medians: 6-month return −4.0%, revenue growth +8.9%, net margin −8.2%, P/E 30.5×.

Short interest

Details →

Shares short5.9M+0.8% vs prior

Days to cover6.2Settled Oct 15

% of float10.5%

Short vol. 10d58.9%of daily volume

Closest peers by size in Surgical Instruments

Company	Price	Today	6M	Rev. growth	Net margin	P/E	Mkt cap
EMBCEmbecta	$6.52	+7.24%	+83.1%	−8.1%	7.8%	4.2	$369.4M
MOBIMobia Medical	$11.24	+12.74%	—	—	−155.8%	—	$374.2M	Compare
OBIOOrchestra BioMed Holdings	$6.00	+7.91%	+46.0%	−89.5%	−27362.5%	—	$360.6M	Compare
OFIXOrthofix Medical Inc. Common Stock (DE)	$9.72	+10.96%	−20.3%	+3.8%	−7.5%	—	$395.9M	Compare
CLPTClearPoint Neuro	$10.16	+4.63%	−11.4%	+36.3%	−61.8%	—	$325.7M	Compare
SIShoulder Innovations	$21.01	+6.00%	+63.0%	—	−59.1%	—	$437.4M	Compare
CARLCarlsmed	$16.09	+11.74%	+63.5%	—	−55.5%	—	$439.3M	Compare
SSIISS Innovations International	$2.27	−2.58%	−44.2%	+39.4%	−19.1%	—	$455.1M	Compare
NPCENeuropace	$13.34	+8.37%	−26.4%	+17.1%	−27.2%	—	$457.9M	Compare

News about Embecta

All news →

EMBECTA CORP. (NASDAQ: EMBC) SHAREHOLDER INVESTIGATION ALERT: Bernstein Liebhard Investigates Potential Breaches of Fiduciary DutyGlobeNewswire Inc. · Sep 22, 2026▼ Negative embecta to Participate in Investor EventsGlobeNewswire Inc. · Aug 31, 2026Neutral EMBC Investors Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit with SBS LawGlobeNewswire Inc. · Aug 10, 2026▼ Negative Embecta Corp. Reports Third Quarter Fiscal 2026 Financial ResultsGlobeNewswire Inc. · Aug 7, 2026Neutral embecta Announces Quarterly Cash DividendGlobeNewswire Inc. · Aug 7, 2026▲ Positive

Quick answers

What does Embecta do?: Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes.
What is EMBC's market cap?: $369.42M, based on the Nov 4 close of $6.52.
What is EMBC's P/E ratio?: 4.2× trailing-twelve-month earnings of $87.50M.
Does Embecta pay a dividend?: Yes. The latest regular dividend was $0.01 per share (ex-date Aug 27), an annualised yield of 0.61%.
How much of EMBC is sold short?: 5.9M shares, 10.5% of float, as of Oct 15, 2026.
What sector is EMBC in?: Healthcare, in the Surgical Instruments industry.

About Embecta

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

HQ: Parsippany, NJ1,850 employeesListed Mar 21, 2022embecta.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology